Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.63 |
| ▸ | MME | P08473 | 2/20 | 0.61 |
| ▸ | ACE | P12821 | 3/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.56 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.56 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.56 |
| ▸ | ECE1 | P42892 | 3/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29577413 | 0.93 | LTA4H (0.66) | LTA4HMMEACEALOX15ERAP2 | |
| SCHEMBL30557742 | 0.93 | LTA4H (0.69) | LTA4HMMEACEALOX15ERAP2 | |
| SCHEMBL2182648 | 0.93 | LTA4H (0.69) | LTA4HMMEACEALOX15ERAP2 | |
| SCHEMBL28067636 | 0.93 | LTA4H (0.69) | LTA4HMMEACEALOX15ERAP2 | |
| SCHEMBL2182644 | 0.93 | LTA4H (0.69) | LTA4HMMEACEALOX15ERAP2 | |
| SCHEMBL11873471 | 0.93 | LTA4H (0.69) | LTA4HMMEACEALOX15ERAP2 | |
| SCHEMBL31477993 | 0.93 | LTA4H (0.69) | LTA4HMMEACEALOX15ERAP2 | |
| SCHEMBL31619984 | 0.93 | LTA4H (0.69) | LTA4HMMEACEALOX15ERAP2 | |
| SCHEMBL11873462 | 0.93 | LTA4H (0.69) | LTA4HMMEACEALOX15ERAP2 | |
| SCHEMBL28067637 | 0.93 | LTA4H (0.69) | LTA4HMMEACEALOX15ERAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114478789-A | anti-PD-L1 and OX40 bispecific antibodies and uses thereof | 安徽安科生物工程（集团）股份有限公司 | 2022-05-13 | — | — | CN | disclosed |